Dawson James Securities Announces Addition of Senior Banking and Capital Market Executives
December 03, 2018 14:36 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc., is pleased to announce the addition of Brandon Ross as Managing Director, Head of Capital Markets and Jonathan Blum...
Dawson James Securities Announces Addition of Veteran Life Science Analyst Jason Kolbert
November 29, 2018 15:54 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc., is pleased to announce the addition of Jason Kolbert as Managing Director, Head of Healthcare Research based in New...
Dawson James Securities 4th Annual Small Cap Growth Conference To be held in Jupiter, Florida on October 29th & 30th, 2018
October 18, 2018 14:24 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. is hosting its 4th Annual Small Cap Growth Conference on October 29th and 30th at the Wyndham Grand Jupiter at...
Dawson James Securities Announces the Closing of Initial Public Offering of Adial Pharmaceuticals, Inc.
August 02, 2018 17:31 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. announced the closing on July 31st of the initial public offering for Adial Pharmaceuticals, Inc. (NASDAQ: ADIL and...
Dawson James Securities Announces the Closing of Public Offering for Sigma Labs, Inc. for Gross Proceeds of $2,390,000
June 27, 2018 17:10 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc. (NASDAQ:SGLB) completed a registered direct offering of 2,390,000 units...
Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc.
June 13, 2018 17:34 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., June 13, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. and Maxim Group LLC acted as dealer-managers on an oversubscribed equity subscription rights offering for PAVmed...
Dawson James Securities Issues Equity Research Microcaps Sector Report
June 01, 2018 09:00 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., June 01, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. issued a sector report “Microcaps Outperforming as Major Microcap Conference Approaches” authored by Barry M. Sine,...
Dawson James Securities Strengthens Biotechnology Franchise with Addition of Wall Street Analyst Carol Ann Werther
April 16, 2018 15:38 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc., is pleased to announce the addition of Carol Ann Werther, Managing Director, Equity Research. Carol has built a...
Dawson James Securities Announces the Completion of $1.0 Million Private Placement Financing for Sigma Labs, Inc.
April 12, 2018 15:28 ET
|
Dawson James Securities, Inc.
BOCA RATON, Fla., April 12, 2018 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc., (NASDAQ:SGLB) has closed on the sale to two purchasers in a private placement...
Dawson James Securities Announces Closing of Initial Public Offering of Spring Bank Pharmaceuticals
May 12, 2016 10:22 ET
|
Dawson James Securities, Inc.
BOCA RATON, FL--(Marketwired - May 12, 2016) -
Dawson James Securities, Inc. a leading, full service investment firm, announced today the closing of an initial public offering of 920,000...